2-octyl-4h-1,3,2-benzodioxaphosphorin-2-oxide has been researched along with Ataxia in 1 studies
*Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casida, JE; Wu, SY | 1 |
1 other study(ies) available for 2-octyl-4h-1,3,2-benzodioxaphosphorin-2-oxide and Ataxia
| Article | Year |
|---|---|
Subacute neurotoxicity induced in mice by potent organophosphorus neuropathy target esterase inhibitors.
Topics: Animals; Ataxia; Biomarkers; Brain; Brain Edema; Carboxylic Ester Hydrolases; Cholinesterase Inhibitors; Enzyme Inhibitors; Isoflurophate; Male; Mice; Organophosphorus Compounds; Paralysis; Paraoxon; Sciatic Nerve; Spinal Cord; Stereoisomerism; Structure-Activity Relationship | 1996 |